Honeywell International Inc. (HON)
TurnaroundFairStock Score: 41/100 — MIXED
Key Financials
| Current Price | $213.24 |
| Market Cap | $150.8B |
| P/E Ratio | 34.01 |
| ROE | 24.26% |
| Dividend Yield | 2.22% |
| Sector | Industrials |
Strengths
- Market-leading positions in aerospace technologies and building automation with durable competitive advantages
- Substantial free cash flow generation of $4.7B supporting dividend capability
- Diversified revenue streams across aerospace, industrial, and energy solutions reduces cyclical risk
- Low beta of 0.90 provides defensive characteristics in market volatility
- 101,000 employee base generating scale efficiencies in established markets
Concerns
- Latest quarter reported negative net income of -$115M signaling serious operational problems
- Valuation divorced from reality: P/E of 31.96 with negative earnings and Graham Number suggesting 93% overvaluation
- Alarming Piotroski F-Score of 3/9 indicates deteriorating financial health and accounting quality
- Poor capital returns: ROCE of 5.95% far below cost of capital despite 26.14% ROE claim, suggesting accounting distortions
- High leverage at 2.37 D/E ratio combined with negative earnings creates refinancing risk
AI Analysis
Looking at Honeywell, I see a conglomerate trading at $237.59 with a market cap of $150.8B that presents a classic case of expensive valuation masking deteriorating fundamentals. A P/E of 31.96 is already concerning, but when I examine the quality of earnings, red flags multiply. The latest quarter shows negative net income of -$115M on $6.9B revenue—a -1.68% margin that's simply unacceptable for a business of this scale. The Graham Number of $15.05 versus current price reveals an absurd 1,478% negative margin of safety. I'm reminded of Graham's principle: we must have substantial protection before committing capital. The Piotroski F-Score of 3/9 indicates deteriorating accounting quality, while the Altman Z-Score of 2.75 sits in the gray zone of financial distress. ROE of 26.14% looks attractive until you examine ROCE of 5.95%—capital allocation is genuinely poor. The $4.7B free cash flow provides some comfort, but an 0.8% FCF yield on this valuation is meager. High leverage at 2.37 D/E ratio combined with negative profitability creates vulnerability. The aerospace and industrial automation segments have competitive positions, but I cannot justify paying premium conglomerate valuations for deteriorating returns and distressed financials.
Bull Case
Honeywell's aerospace segment benefits from secular tailwinds in commercial aviation recovery and defense spending increases. The company's free cash flow generation and industrial automation positions in smart buildings could support dividend continuation and eventual margin recovery as supply chain normalizes.
Bear Case
The negative earnings in Q4 2025 combined with poor ROCE suggests structural operational challenges, not temporary headwinds. If margins don't recover and leverage increases, this conglomerate could face dividend cuts, covenant violations, and significant shareholder dilution—classic distress patterns.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer